Venture Investors
Venture Investors is a premier provider of seed and early stage venture capital in the Midwest.
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Venture Investors Information
Geographic Data
Address: 505 S Rosa Rd
City: Madison
State: WI
Zip: 53719
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$100M
Social
Twitter
Linkedin
Crunchbase
Metrics
9,480,362Website Global Rank
147Website Monthly Traffic
Twitter Followers
Description
Turning innovation into health. Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have over $200 million in assets under management.
Contact Phone:
+16084412700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2017 | TAI Diagnostics | Venture Round | 1.8M |
| 6/2020 | EnsoData | Series A | 9M |
| 8/2015 | ReShape Lifesciences | Post-IPO Equity | 38M |
| 9/2014 | Prevacept Infection Control | Venture Round | 0 |
| 9/2015 | Delphinus Medical Technologies | Series C | 0 |
| 4/2011 | Akebia Therapeutics | Series B | 0 |
| 1/2017 | Madison Vaccines | Venture Round | 3.3M |
| 3/2015 | Madison Vaccines | Series A | 3M |
| 11/2012 | BlueWillow Biologics | Series C | 0 |
| 1/2012 | Aerpio Pharmaceuticals | Venture Round | 5M |
| 9/2002 | InterSymbol Communications | Series A | 5M |
| 2/2020 | Eximis Surgical | Series A | 17M |
| 1/2015 | Silatronix | Venture Round | 2.1M |
| 5/2015 | NeuWave Medical | Series C | 25.3M |
| 7/2009 | Akebia Therapeutics | Series A | 25M |
| 1/2008 | Pattern Insight | Series A | 3M |
| 6/2020 | HistoSonics | Series C | 40M |
| 12/2002 | Chromatin | Series A | 0 |
| 4/2006 | Chromatin | Venture Round | 0 |
| 10/2015 | TAI Diagnostics | Series A | 8.2M |
| 8/2013 | Tissue Regeneration Systems | Series B | 4.6M |
| 3/2007 | Mithridion | Series A | 2.2M |
| 5/2014 | HistoSonics | Series A | - |
| 2/2014 | UpTo | Series A | 670k |
| 5/2008 | Silatronix | Seed Round | 500k |
| 9/2022 | Delphinus Medical Technologies | Series D | 0 |
| 2/2008 | NERITES | Series A | 5.7M |
| 2/2008 | NeuWave Medical | Series A | 4.5M |
| 12/1984 | Promega | Venture Round | - |
| 4/2022 | EnsoData | Series A | 0 |
| 5/2008 | Tissue Regeneration Systems | Series A | 2M |
| 12/2019 | SkySpecs | Series C | 0 |
| 12/2004 | Zystor | Series A | 0 |
| 1/2015 | Thalchemy | Funding Round | 250k |
| 6/2014 | Thalchemy | Seed | 650k |
| 5/2016 | FluGen | Venture Round | 0 |
| 9/2007 | Virent Energy Systems | Series B | 0 |
| 7/2009 | BlueWillow Biologics | Series B | 0 |
| 3/2017 | HistoSonics | Series B | 0 |
| 4/2017 | FluGen | Series A | 0 |
| 8/2015 | FluGen | Series A | 0 |
| 2/2010 | HistoSonics | Series A | 0 |
| 1/2011 | Celleration | Series E | 0 |
| 11/2013 | Silatronix | Venture Round | 0 |
| 3/2001 | Corona Optical Systems | Series A | 12.1M |
| 11/2018 | Eximis Surgical | Venture Round | 7.5M |
| 4/2003 | Roche NimbleGen | Series D | 0 |
| 4/2014 | Aerpio Pharmaceuticals | Series C | 0 |
| 3/2017 | Aerpio Pharmaceuticals | Venture Round | 0 |
| 1/2017 | Elucent Medical | Series A | 7.2M |
| 9/2015 | Silatronix | Venture Round | 0 |
| 11/2004 | Roche NimbleGen | Series F | 12.8M |
| 4/2014 | Neurovance | Series A | 6.3M |
| 7/2000 | Gala Biotech | Venture Round | 0 |
| 10/2001 | Roche NimbleGen | Series B | 10.5M |
| 7/2002 | Celleration | Series B | 0 |
| 7/2012 | Juventas Therapeutics | Series B | 0 |
| 10/2009 | Inviragen | Series A | 0 |
| 7/1994 | Third Wave Technologies | Series A | 300k |
| 12/2007 | Deltanoid Pharmaceuticals | Series B | 12M |
| 1/2011 | Mithridion | Series C | 1.3M |
| 11/2015 | SkySpecs | Series A | 0 |
| 11/2021 | ViaLase | Series A | 27.3M |
| 1/2009 | Mithridion | Series B | 2.9M |
| 4/2014 | NeuMoDx Molecular | Series B | 21M |
| 12/2022 | HistoSonics | Convertible Note | 85M |
| 3/2011 | Euthymics Bioscience | Series A | 4M |
| 6/2016 | Silatronix | Venture Round | 8M |
| 3/2009 | LensX Lasers | Series B | 22.4M |
| 4/2013 | Netsocket | Series B | 9.2M |
| 4/2019 | HistoSonics | Series C | 0 |
| 11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
| 6/2006 | Virent Energy Systems | Series A | 0 |
| 1/2008 | Cellectar Biosciences | Venture Round | 13M |
| 1/2020 | Health Scholars | Series B | 0 |
| 6/2013 | UpTo | Series A | 2M |
| 2/1999 | TomoTherapy | Series A | 3M |
| 1/2015 | Silatronix | Funding Round | 2.1M |
| 8/2017 | HealthMyne | Series A | - |
| 3/2015 | HealthMyne | Series A | 4.5M |
| 1/2018 | SkySpecs | Series B | 0 |
| 6/2013 | Akebia Therapeutics | Series C | 0 |
| 1/2014 | Cellectar Biosciences | Post-IPO Equity | 4M |
| 8/2018 | HealthMyne | Series B | 15M |
| 8/2012 | NeuWave Medical | Equity | 14M |
| 4/2007 | Incept BioSystems | Series A | 3.3M |
| 9/2016 | HealthMyne | Venture Round | 6.9M |
| 10/2012 | ReShape Lifesciences | Post-IPO Equity | 15M |
| 6/2015 | Neurovance | Series A | 6.5M |
| 10/2000 | IntraLase | Venture Round | 22M |
| 10/2018 | Invenra | Series B | 0 |
| 5/2000 | Alfalight | Series A | 6.1M |
| 6/2013 | Getnextt | Seed Round | 700k |
| 5/2007 | ProCertus BioPharm | Series A | 2.3M |
| 7/2009 | ProCertus BioPharm | Venture Round | 2.1M |
| 1/2014 | Madison Vaccines | Series A | 8M |
| 7/2000 | SoftSwitching Technologies | Series B | 6.2M |
| 4/2022 | EnsoData | Series A | 0 |
| 11/2021 | ViaLase | Series A | 0 |
| 6/2020 | EnsoData | Series A | 0 |
| 6/2020 | HistoSonics | Series C | 0 |
| 2/2020 | Eximis Surgical | Series A | 0 |
| 1/2020 | Health Scholars | Series B | 0 |
| 12/2019 | SkySpecs | Series C | 0 |
| 4/2019 | HistoSonics | Series C | 0 |
| 11/2018 | Eximis Surgical | Venture Round | 0 |
| 10/2018 | Invenra | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
